EP Patent

EP2757161A1 — miRNA-124 as a biomarker of viral infection

Assigned to Centre National de la Recherche Scientifique CNRS · Expires 2014-07-23 · 12y expired

What this patent protects

A use of at least one miRNA, said at least one miRNA being miR-124, as a biomarker of a viral infection, or of an efficacy of a therapeutic treatment of said viral infection.

USPTO Abstract

A use of at least one miRNA, said at least one miRNA being miR-124, as a biomarker of a viral infection, or of an efficacy of a therapeutic treatment of said viral infection.

Drugs covered by this patent

Patent Metadata

Patent number
EP2757161A1
Jurisdiction
EP
Classification
—
Expires
2014-07-23
Drug substance claim
No
Drug product claim
No
Assignee
Centre National de la Recherche Scientifique CNRS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.